This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical breakthrough

New Genetic Ties to Anxiety

Analysis based on 6 articles · First reported Jun 09, 2026 · Last updated Jun 15, 2026

Sentiment
20
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

This medical breakthrough by King s College London and QIMR Berghofer could lead to new diagnostic tools and treatments for anxiety, positively impacting the biotechnology and pharmaceutical industries. Companies involved in genetic research and drug development for mental health conditions may see increased investment and opportunities. The findings also highlight the interconnectedness of mental and physical health, potentially influencing healthcare strategies and research funding.

Biotechnology Pharmaceuticals Healthcare

Researchers from King s College London and QIMR Berghofer conducted a genome-wide association study (GWAS) on nearly 700,000 people of European ancestry, identifying 74 genetic locations linked to anxiety symptoms, with 39 being novel. Published in Nature Human Behaviour, this research provides the largest number of genetic associations with anxiety to date, offering new insights into the biological continuum of the condition. Key genes like PCLO and SORCS3 were implicated, and the study found that common genetic variation explains about 6% of anxiety symptom severity differences. The research also highlighted significant genetic correlations between anxiety and various mental and physical health conditions, including depression, irritable bowel syndrome, chronic pain, coronary artery disease, endometriosis, and migraine. The study was supported by organizations such as the United States — National Institutes of Health, Wellcome Trust, United Kingdom — Medical Research Council, United Kingdom — National Institute for Health and Care Research, and United Kingdom — Medical Research Council.

per
Thalia C. Eley, Professor at King s College London, was a lead author of the study, playing a crucial role in its direction and findings.
Importance 80.0 Sentiment 20.0
per
Megan Skelton, Research Fellow at King s College London, was the first author of the study, contributing significantly to the research and its interpretation.
Importance 80.0 Sentiment 20.0
per
Brittany Mitchell, Team Head at QIMR Berghofer, was a co-first author, highlighting the interconnection between mental and physical health.
Importance 80.0 Sentiment 20.0
ngo
The Psychiatric Genomics Consortium was the organizational output of the study, focusing on meta- and mega-analyses of psychiatric genetic studies.
Importance 60.0 Sentiment 10.0
govactor
The United Kingdom — National Institute for Health and Care Research supported the researchers, contributing to the funding of the study.
Importance 40.0 Sentiment 10.0
govactor
The United Kingdom — Medical Research Council supported the researchers, providing funding for the study.
Importance 40.0 Sentiment 10.0
govactor
ngo
Importance 0 Sentiment 0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.